Sonic Healthcare Ltd (SKHHY)
17.54
+0.13
(+0.76%)
USD |
OTCM |
May 09, 16:10
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 8.426B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -25.75% |
| Valuation | |
| PE Ratio | 24.86 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.506 |
| Price to Book Value | 1.604 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.2820 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.5173 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 47.65% |
Profile
| Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand, and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S., and 35% in Europe. |
| URL | https://www.sonichealthcare.com |
| Investor Relations URL | https://investors.sonichealthcare.com |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Aug. 16, 2024 (est.) |
| Last Earnings Release | Feb. 20, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 01, 2024 |
Ratings
Profile
| Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand, and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S., and 35% in Europe. |
| URL | https://www.sonichealthcare.com |
| Investor Relations URL | https://investors.sonichealthcare.com |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Aug. 16, 2024 (est.) |
| Last Earnings Release | Feb. 20, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 01, 2024 |